Global Liver Institute
News
GLOBAL LIVER INSTITUTE
Charting the Course of NASH
The 6th International NASH Day was a resounding global success, with over 100 partners from 55 countries participating.
Noteworthy Progress in Patient Advocacy & Clinical Trials
Actively supporting advocacy efforts and engaging in novel clinical trials can provide patients with a sense of hope for potential therapies and assurance in the management of their condition.
Discoveries in HCC and Biliary Tract Cancer
It’s not only important to GLI to keep you updated; we value your input and updates.
GLI Leads Bipartisan Access to Innovation Strategy Across HHS, Congress, and the White House
We have so much more to do to support liver health and appreciate your consistent engagement and support in those efforts!
GLI provided comments to FDA on the importance of patient preference information (PPI)
Well-designed and well-conducted PPI studies elicit which attributes are important to patients, how important they are, and what trade-offs patients are willing to make.
GLI to Address Need for NAFLD/NASH Nomenclature Implementation Plan
GLI to Address Need for NAFLD/NASH Nomenclature Implementation Plan Since the joint medical society announcement of the change in nomenclature for NAFLD at the recent International Liver...
GLI Continues to Advocate for Liver Patients with the Biden Administration, Congress and Federal Agencies
While a divided Congress and the upcoming Presidential campaign year make for challenging times for policymakers, Global Liver Institute is committed to advocating for liver patients at all levels of regulatory and legislative decision making.
Growth in Patient and Medical Community Engagement in NASH Community Persists Despite Recent Regulatory Disappointment
Today is International NASH Day, a time where healthcare experts and community members around the globe step up and raise awareness of the most common liver disease in the world – nonalcoholic fatty liver disease (NAFLD) – and it’s more severe form, nonalcoholic steatohepatitis (NASH).
Efforts for Improved Treatment and Diagnosis of Rare Liver Diseases
In this month’s edition, we feature the latest initiatives that GLI has taken part in to advocate for policy changes and highlight new innovations in the rare liver disease field to allow for better research opportunities and improved patient outcomes.
New Leadership & New Understanding in the Cancer World
Globally, liver cancer is the third leading cause of cancer death. It’s not only important to GLI to keep you updated; we value your input and updates.
It’s time to #StepUpforNASH
How do you plan to #StepUpforNASH? Learn more about how you can get involved today!
Support Legislation to Protect Living Organ Donors
Global Liver Institute is proud to support H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act. This bipartisan legislation responds to the urgent need for reforming the Organ Procurement Transplantation Network (OTPN), breaking up the national monopoly contract so that the Health Resources Services Administration (HRSA) can run an open, competitive process and choose from the best of the best in each field (e.g., health policy, IT, logistics, patient safety) to save more lives.